News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Endius, Inc. Receives Six New Patents Relating To Its MIS Spine Surgery Product Portfolio



9/26/2006 12:32:16 PM

PLAINVILLE, Mass., Sept. 26 /PRNewswire/ -- Endius Incorporated has been issued six new patents in 2006 relating to its portfolio of minimally-invasive spine surgery products, the company announced today at the annual meeting of the North American Spine Society in Seattle.

Michael McCarthy, president and CEO of Endius, said the company has 40 issued patents with 87 additional patent applications pending worldwide. "We have been investing significantly in research and development and our hard work is starting to pay off," McCarthy said. "We continue to build on our very strong intellectual property portfolio involving instrumentation, spinal implants and minimally-invasive surgical access."

Gene DiPoto, vice president of R&D for Endius, said that "unique access and instrumentation is required to enable surgeons to perform surgery through a less-invasive means". "This has been a real focus for Endius and, as a result, many unique instruments, implants and access devices have been created to enable the procedure to be performed minimally-invasively and to ease the surgical procedure for the spine surgeon."

The latest patents include claims involving minimally-invasive access devices, unique MIS instrumentation, implants designed for delivery through a MIS means and surgical methods surrounding the use of these various systems.

Founded in 1997, Endius is a pioneer in the development of breakthrough minimally-invasive spine surgery products and implants to treat serious spine disease. The company's Atavi System is the only fully integrated system that enables surgeons to perform spine surgery minimally-invasively while preserving the fundamentals of traditional open surgical technique. More than 200 surgeons have now been trained to use the Atavi system and more than 2,000 surgical procedures have been successfully completed. For more information on Endius, visit the company's website at http://www.endius.com .

For more information: Mark Leonard 847.267.9660 mark@reachthenextlevel.com

Endius Incorporated

CONTACT: Mark Leonard of Endius Incorporated, +1-847-267-9660,mark@reachthenextlevel.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES